Alcon Inc (ALC) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Alcon Inc (ALC) stock forecast summary
Our AI ranks Alcon Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Alcon Inc is a large-cap company with a market capitalization of $30.71B. It ranks number 1 by market capitalization among the 8 Ophthalmic Goods issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for ALC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ALC included.
Follow ALC freeALC price chart and AI forecast
How ALC ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Alcon Inc (ALC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Ophthalmic Goods peers listed below that report each metric.
Valuation & Market
| Metric | ALC | Rank |
|---|---|---|
| Market Cap | $30.71B | 1/8 |
| EPS | $7.27 | – |
Profitability & Margins
| Metric | ALC | Rank |
|---|---|---|
| Tax Rate | 12.5% | – |
Financial Health
| Metric | ALC | Rank |
|---|---|---|
| Interest Coverage | 36.0x | 2/6 |
Cash Flow
| Metric | ALC | Rank |
|---|---|---|
| Operating Cash Flow | $2.38B | 1/8 |
Income Statement
| Metric | ALC | Rank |
|---|---|---|
| Operating Income | $2.48B | 1/7 |
| R&D Expense | $747M | 1/6 |
| Cost of Goods Sold | $1.68B | 1/7 |
Dividend & Shareholder Information
| Metric | ALC | Rank |
|---|---|---|
| Shares Outstanding | 487M | – |
ALC quarterly financials and insider trading
Alcon Inc (ALC) industry peers
Companies classified under the same SEC industry code as Alcon Inc (Ophthalmic Goods): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| ALC Alcon Inc | ▼ | $30.71B |
| COO Cooper Companies, Inc. | ▼ | $10.38B |
| BLCO Bausch & Lomb Corp | ▶ | $5.65B |
| WRBY Warby Parker Inc. | ▲ | $3.28B |
| EYE National Vision Holdings, Inc. | ▼ | $1.35B |
| STAA Staar Surgical Co | ▶ | $1.08B |
| RXST Rxsight, Inc. | ▲ | $188M |
| LUCY Innovative Eyewear Inc | ▲ | $7M |
Where ALC sits on the market map
Alcon Inc (ALC) stock news
Loading...
Alcon Inc (ALC) stock forecast FAQ
What is the Alcon Inc (ALC) stock forecast?
Our AI ranks Alcon Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Alcon Inc stock predictions?
A per-ticker accuracy statistic for ALC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Alcon Inc forecasts updated?
Alcon Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Alcon Inc's industry peers?
8 issuers in our coverage, ALC included, share the SEC industry code Ophthalmic Goods. The largest are: Cooper Companies, Inc. (COO), Bausch & Lomb Corp (BLCO), Warby Parker Inc. (WRBY), National Vision Holdings, Inc. (EYE), Staar Surgical Co (STAA), Rxsight, Inc. (RXST).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.